Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 May;11(1):43–50.

Antibody responses to herpesviruses (EBV, HSV and CMV) in cancer patients given cultured lymphoblastoid cells

J Minowada, G E Moore, R E Gerner, J S Matheisz
PMCID: PMC1553679  PMID: 4338950

Abstract

Infusion of cultured human lymphoblastoid cells into ten patients with advanced malignancies resulted in a significant rise in antibody titre to Epstein-Barr virus in all ten. There was a significant rise in antibody titre to herpes simplex virus (HSV) in six of the ten patients. The four patients who did not respond in their antibody to HSV had no detectable HSV antibody before the cell infusion. In contrast, four patients had detectable antibody titre to cytomegalovirus (CMV) prior to the cell infusion; none of the ten showed a rise in CMV antibody after cell infusion. Observed antibody responses to EBV and HSV occurred regardless of the presence or absence of detectable herpesviruses in the lymphoblastoid cell lines infused. Six of the ten patients, negative for the heterophile antibody before cell infusion, developed a significant titre of the heterophile antibody after infusion.

Except for the heterophile antibody response, the failure to detect IgM antibody to Epstein-Barr virus and to induce antibody to herpes simplex virus in the nonimmune patients suggests that the observed antibody responses are secondary responses.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dalldorf G., Carvalho R. P., Jamra M., Frost P., Erlich D., Marigo C. The lymphomas of Brazilian children. JAMA. 1969 May 26;208(8):1365–1368. [PubMed] [Google Scholar]
  2. Epstein M. A., Achong B. G. Specific immunofluorescence test for the herpes-type EB virus of Burkitt lymphoblasts, authenticated by electron microscopy. J Natl Cancer Inst. 1968 Mar;40(3):593–607. [PubMed] [Google Scholar]
  3. Evans A. S., Niederman J. C., McCollum R. W. Seroepidemiologic studies of infectious mononucleosis with EB virus. N Engl J Med. 1968 Nov 21;279(21):1121–1127. doi: 10.1056/NEJM196811212792101. [DOI] [PubMed] [Google Scholar]
  4. Evans A. S., Rothfield N. F., Niederman J. C. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet. 1971 Jan 23;1(7691):167–168. doi: 10.1016/s0140-6736(71)91937-4. [DOI] [PubMed] [Google Scholar]
  5. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hampar B., Gerber P., Hsu K. C., Martos L. M., Walker J. L., Sigüenza R. F., Wells G. A. Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera. J Natl Cancer Inst. 1970 Jul;45(1):75–85. [PubMed] [Google Scholar]
  7. Hellström I., Hellström K. E., Pierce G. E., Yang J. P. Cellular and humoral immunity to different types of human neoplasms. Nature. 1968 Dec 28;220(5174):1352–1354. doi: 10.1038/2201352a0. [DOI] [PubMed] [Google Scholar]
  8. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henle W., Henle G., Scriba M., Joyner C. R., Harrison F. S., Jr, Von Essen R., Paloheimo J., Klemola E. Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. N Engl J Med. 1970 May 7;282(19):1068–1074. doi: 10.1056/NEJM197005072821904. [DOI] [PubMed] [Google Scholar]
  11. Hirshaut Y., Glade P., Moses H., Manaker R., Chessin L. Association of herpes-like virus infection with infectious mononucleosis. Am J Med. 1969 Oct;47(4):520–527. doi: 10.1016/0002-9343(69)90182-x. [DOI] [PubMed] [Google Scholar]
  12. Hirshaut Y., Glade P., Vieira B. D., Ainbender E., Dvorak B., Siltzbach L. E. Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. N Engl J Med. 1970 Sep 3;283(10):502–506. doi: 10.1056/NEJM197009032831002. [DOI] [PubMed] [Google Scholar]
  13. Klein G., Clifford P., Klein E., Stjernswärd J. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A. 1966 Jun;55(6):1628–1635. doi: 10.1073/pnas.55.6.1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med. 1968 Nov 1;128(5):1011–1020. doi: 10.1084/jem.128.5.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Levine P. H., Ablashi D. V., Berard C. W., Carbone P. P., Waggoner D. E., Malan L. Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer. 1971 Feb;27(2):416–421. doi: 10.1002/1097-0142(197102)27:2<416::aid-cncr2820270227>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  16. Moore G. E., Gerner R. E. Cancer immunity--hypothesis and clinical trial of lymphocytotherapy for malignant diseases. Ann Surg. 1970 Oct;172(4):733–739. doi: 10.1097/00000658-197010000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moore G. E., Moore M. B. Auto-inoculation of cultured human lymphocytes in malignant melanoma. N Y State J Med. 1969 Feb 1;69(3):460–462. [PubMed] [Google Scholar]
  18. Morton D. L., Malmgren R. A. Human osteosarcomas: immunologic evidence suggesting an associated infectious agent. Science. 1968 Dec 13;162(3859):1279–1281. doi: 10.1126/science.162.3859.1279. [DOI] [PubMed] [Google Scholar]
  19. Porter D. D., Wimberly I., Benyesh-Melnick M. Prevalence of antibodies to EB virus and other herpesviruses. JAMA. 1969 Jun 2;208(9):1675–1679. [PubMed] [Google Scholar]
  20. Stevens D. A., Pry T. W., Manaker R. A. Infectious mononucleosis--always a primary infection with herpes-type virus? J Natl Cancer Inst. 1970 Mar;44(3):533–537. [PubMed] [Google Scholar]
  21. Viza D., Davies D. A., Harris R. Solubilization and partial purification of human leukaemic specific antigens. Nature. 1970 Sep 19;227(5264):1249–1251. doi: 10.1038/2271249a0. [DOI] [PubMed] [Google Scholar]
  22. de Schryver A., Friberg S., Jr, Klein G., Henle W., Henle G., De-Thé G., Clifford P., Ho H. C. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol. 1969 Nov;5(5):443–459. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES